Author

Mizuki Yamazaki

Observed names: MIZUKI YAMAZAKI, Mizuki YAMAZAKI

Institution: Gifu Pharmaceutical University

Observed institutions: Gifu Pharmaceutical University, Gifu University Hospital, Gifu University

ORCID: 0009-0002-1901-0535

Observed ORCID: 0009-0002-1901-0535

OpenAlex ID: A5076522597

Cancer cachexia as a determinant of efficacy of first‑line pembrolizumab in patients with advanced non‑small cell lung cancer

2022 · Hironori Fujii, Ayumu Araki, et al. · Molecular and Clinical Oncology · 15

Relationship Between Osimertinib Concentration and Clinical Response in Japanese Patients With Non-small Cell Lung Cancer

2023 · MIZUKI YAMAZAKI, NAO KOMIZO, et al. · Anticancer Research · 11

Mirtazapine plus granisetron and dexamethasone for carboplatin-induced nausea and vomiting in patients with thoracic cancers: A prospective multicenter phase II trial

2024 · Hirotoshi Iihara, Masamichi Iwai, et al. · Lung Cancer · 2

Simultaneous and Rapid Determination of Plasma Concentrations of Four Tyrosine Kinase Inhibitors Using Liquid Chromatography/Tandem Mass Spectrometry in Patients with Non–Small Cell Lung Cancer

2023 · Mizuki YAMAZAKI, Nao KOMIZO, et al. · Chromatography · 2

Primary care education in undergraduate pharmacy programs in Japan: A nationwide content analysis of publicly available syllabi

2026 · Shota Kiuchi, Mizuki Yamazaki, et al. · Currents in Pharmacy Teaching and Learning · 1

Gaps in primary health care education in Japanese pharmacy curricula

2026 · Hayase Hakariya, Shota Kiuchi, et al. · QJM

Works count: 6

Citation count: 31

H-index: 2

I10-index: 2